Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/15/1995 | EP0681474A1 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
11/15/1995 | EP0681473A1 Compositions containing tandospirone or its analogs |
11/15/1995 | EP0681472A1 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents |
11/15/1995 | EP0681471A1 Pharmaceutical compositions comprising cyclodextrin inclusion complexes of the compound ci-979 |
11/15/1995 | EP0615446B1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation |
11/15/1995 | EP0551434B1 High affinity tamoxifen derivatives and uses thereof |
11/15/1995 | EP0536369B1 4-hydroxy butyric acid derivatives |
11/15/1995 | EP0532668B1 Novel alpha-glucosidase inhibitors |
11/15/1995 | EP0491864B1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
11/15/1995 | EP0484333B1 Nucleoside derivatives and their use as medicaments |
11/15/1995 | EP0238545B1 C20 through c26 amino steroids |
11/15/1995 | CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
11/15/1995 | CN1111900A Antitussive |
11/15/1995 | CN1111639A Liponucleotide compounds |
11/15/1995 | CN1111638A Sulfated-glycolipid derivatives as cell adhesion inhibitors |
11/15/1995 | CN1111637A Phosphonooxymethyl ethers of taxane derivatives |
11/15/1995 | CN1111634A Derivative of thienothiazine |
11/15/1995 | CN1111633A Process for preparing cephalosporin compounds from reactive organic acid derivatives |
11/15/1995 | CN1111632A Imidazodiazepine |
11/15/1995 | CN1111631A Neue 3-phenylsulfonyl-3,7-diazabicyclo|3,3,1¨nonan-verbindungen enthaltende arzneimittel |
11/15/1995 | CN1111630A Adhesion receptor antagonists |
11/15/1995 | CN1111629A 5-vinyl- and 5-ethinyl-quinolone- and -naphthyridone-carboxyhic acids |
11/15/1995 | CN1111626A Preparation and the pharmaceutical compositions which contain them |
11/15/1995 | CN1111622A Propenoic acid derivaties |
11/15/1995 | CN1111620A New alkylaminoindane compounds, processes for preparing them and pharmaceutical compositions containing them |
11/15/1995 | CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
11/15/1995 | CN1111513A Fungicidal compositions containing bifonazole |
11/15/1995 | CN1111512A Medical composition for prevention of early pregnancy |
11/15/1995 | CN1111511A Combination treatment for osteoporosis |
11/15/1995 | CN1111510A Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
11/15/1995 | CN1111509A Protracted-release administration forms containing clindamycin palmitate |
11/15/1995 | CN1111508A Fatty acid derivatives |
11/15/1995 | CN1111507A Controlled release oxybutynin formulations |
11/15/1995 | CN1111506A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
11/15/1995 | CN1030253C Methylenebisphosphonic acid derivatives |
11/15/1995 | CN1030252C Tetrahydrobenzimidazole derivative |
11/15/1995 | CN1030251C Substituted 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives |
11/14/1995 | US5466865 Neomorphic ibuprofen and methods of using same |
11/14/1995 | US5466861 Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors |
11/14/1995 | US5466833 Cyclopenta(b)furan intermediates |
11/14/1995 | US5466829 Platelet aggregation inhibiting effect |
11/14/1995 | US5466826 Process for preparing a physical form of pharmaceutical agent |
11/14/1995 | US5466823 Antiinflammatory agents; FDA Orange book listed patent for Celebrex |
11/14/1995 | US5466820 Production of Di or tri-azolyl substituted 5-keto azole compounds |
11/14/1995 | US5466815 Antilipemic agents |
11/14/1995 | US5466811 Dioxolenylmethyl carbamates pro moieties for amine drugs |
11/14/1995 | US5466810 Estrogen inhibitors |
11/14/1995 | US5466809 Process for the preparation of immunostimulating swainsonine analogs |
11/14/1995 | US5466808 8-sulfo-3-quinoline carboxylic acids and process therefore |
11/14/1995 | US5466786 2'modified nucleoside and nucleotide compounds |
11/14/1995 | US5466782 Method for separating a compound containing glycolipids, lysophospholipids, sphingolipids and ceramides of plant origin |
11/14/1995 | US5466719 Polyglycerol fatty acid ester mixture |
11/14/1995 | US5466718 Tyrosinase inhibitors |
11/14/1995 | US5466714 Spermicidal and cytocidal fatty acid compositions |
11/14/1995 | US5466713 Iloprost with action against cerebral malaria |
11/14/1995 | US5466712 Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones |
11/14/1995 | US5466711 Medicaments |
11/14/1995 | US5466709 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes |
11/14/1995 | US5466706 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application |
11/14/1995 | US5466702 Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment |
11/14/1995 | US5466701 Saccharin derivative proteolytic enzyme inhibitors |
11/14/1995 | US5466700 Anesthetic use of N-phenyl-N-(4-piperidinyl)amides |
11/14/1995 | US5466699 (S)-N,N-dimethyl-2-(5-(2-oxo-1,3-oxazolidin -4-ylmethyl)-1H-indole-3-yl)ethylamine; zolmitriptan |
11/14/1995 | US5466698 Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents |
11/14/1995 | US5466697 8-phenyl-1,6-naphthyridin-5-ones |
11/14/1995 | US5466696 Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
11/14/1995 | US5466695 Method for stimulating hair growth with cationic derivative of minoxidil using therapeutic iontophoresis |
11/14/1995 | US5466694 Compositions for slowing down hair loss and for inducing and stimulating its growth, based on 2,4-diamino-pyrimidine 3-oxide derivatives, and new 2,4-diaminopyrimidine 3-oxide derivatives |
11/14/1995 | US5466692 Substituted pyridopyrimidines and antihypertensives |
11/14/1995 | US5466690 Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity |
11/14/1995 | US5466686 Microbiocides |
11/14/1995 | US5466685 Permit treatment of infections of otherwise resistive bacteria with antibiotics |
11/14/1995 | US5466684 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
11/14/1995 | US5466682 Bone disorders |
11/14/1995 | US5466678 Potentiating antitumor activity |
11/14/1995 | US5466677 Dinucleoside phosphinates and their pharmaceutical compositions |
11/14/1995 | US5466675 Immunological activity of rhamnolipids |
11/14/1995 | US5466596 Genetic engineering |
11/14/1995 | US5466584 Oxytocin receptor and DNA coding therefor |
11/14/1995 | US5466468 Zinc phthalocyanine and a phospholipid |
11/14/1995 | US5466451 Carbon dioxide, supercritical |
11/14/1995 | US5466450 From Kibdelosporangium, treatment of herpes simplex |
11/14/1995 | US5466445 Orally administering ethylenediamine modified ethylene oxide-propylene oxide octablock copolymer |
11/14/1995 | US5466436 Medicaments for treating inflammatory conditions or for analgesia |
11/14/1995 | CA2149282A1 Gemfibrozil containing pharmaceutical compositions |
11/14/1995 | CA2045481C Immunosupressing agent and process of producing the same |
11/14/1995 | CA1337565C Procyanidol oligomeric fractions, the processes for the preparation thereof and pharmaceutical compositions containing them |
11/14/1995 | CA1337564C 7-(1-pyrrolidinyl)-quinolonecarboxylic acid derivatives and their use as antibacterials and animal feed utilization promoters |
11/14/1995 | CA1337549C Method for the treatment of ulcerative proctitis and colitis |
11/14/1995 | CA1337548C Fatty acid composition |
11/13/1995 | CA2148037A1 Method and compositions for the treatment of infant or adult respiratory distress syndrome |
11/12/1995 | CA2149093A1 Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives |
11/12/1995 | CA2149092A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene-derivatives |
11/12/1995 | CA2149091A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
11/12/1995 | CA2148866A1 8-amino-10-(azabicycloalkyl)-pyrido[1,2,3-d,e][1,3,4] benzoxadiazine derivatives |
11/12/1995 | CA2148865A1 8-amino-pyrido(1,2,3-d,e)(1,3,4)benzoxadiazine derivatives |
11/11/1995 | CA2148951A1 5,6-dihydro-4h-imidazo[2',1':2,3]imidazo-[4,5,1-ij] quinoline and 4,5-dihydroimidazo-[1,2-a]pyrrolo[1,2,3-cd] benzimidazole derivatives, their preparation and application in therapeutics |
11/11/1995 | CA2148880A1 5,6-dihydro-4h-thieno[3,4-c]pyrrole derivatives; process for preparing the same and their use as therapeutic agents |
11/11/1995 | CA2147587A1 Method and composition for prophylaxis and treatment of retinal diseases |
11/09/1995 | WO1995029932A1 Process for the preparation of 4-amino-δ4-3-ketosteroids via 4-nitro-δ4-3-ketosteroids |